Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2021 Jul 26

PMID 34305395

Citations 3

Authors

Ahmed R Gardouh

Ahmed S G Srag El-Din

Mohamed S H Salem

Yasser Moustafa

Shadeed Gad

Affiliations

Soon will be listed here.

Abstract

Purpose: This research aimed to improve water solubility and oral bioavailability of a newly synthesized thienopyrimidine derivative (TPD) with anti-pancreatic cancer activity by loading on starch nanoparticles (SNPs).

Methods: TPD was synthesized, purified and its ADME behavior was predicted using Swiss ADME software. A UV spectroscopy method was developed and validated to measure TPD concentration at various dosage forms. SNPs loaded with TPD (SNPs-TPD) were prepared, characterized for particle size, polydispersity index, zeta potential, transmission electron microscopy, Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), entrapment efficiency, in-vitro release, and in-vivo animal study.

Results: The Swiss ADME results showed that TPD can be administered orally; however, it has low oral bioavailability (0.55) and poor water solubility. The significant regression coefficient of the calibration curve (r = 0.9995), the precision (%RSD < 0.5%) and the accuracy (99.46-101.72%) confirmed the efficacy of the developed UV method. SNPs-TPD had a spherical monodispersed (PDI= 0.12) shape, nanoparticle size (22.98 ± 4.23) and good stability (-21 ± 4.72 mV). Moreover, FT-IR and DSC revealed changes in the physicochemical structure of starch resulting in SNPs formation. The entrapment efficiency was 97% ± 0.45%, and the in-vitro release showed that the SNPs enhanced the solubility of the TPD. The in-vivo animal study and histopathology showed that SNPs enhanced the oral bioavailability of TPD against solid Ehrlich carcinoma.

Conclusion: SNPs-TPD were superior in drug solubility and oral bioavailability than those obtained from TPD suspension.

Citing Articles

Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges.

Wu X, Xin Y, Zhang H, Quan L, Ao Q Int J Nanomedicine. 2024; 19:7415-7471.

PMID: 39071502 PMC: 11278852. DOI: 10.2147/IJN.S460047.

Development and Evaluation of a Self-Nanoemulsifying Drug Delivery System for Sinapic Acid with Improved Antiviral Efficacy against SARS-CoV-2.

Alhadrami H, El-Din A, Hassan H, Sayed A, Alhadrami A, Rateb M Pharmaceutics. 2023; 15(11).

PMID: 38004511 PMC: 10674535. DOI: 10.3390/pharmaceutics15112531.

New anionic cobalt(III) complexes enable enantioselective synthesis of spiro-fused oxazoline and iodoacetal derivatives.

Salem M, Takizawa S Front Chem. 2022; 10:1034291.

PMID: 36311431 PMC: 9606352. DOI: 10.3389/fchem.2022.1034291.

References

Cisternino S, Bourasset F, Archimbaud Y, Semiond D, Sanderink G, Scherrmann J . Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats. Br J Pharmacol. 2003; 138(7):1367-75. PMC: 1573768. DOI: 10.1038/sj.bjp.0705150. View

Ahmad M, Gani A, Hassan I, Huang Q, Shabbir H . Production and characterization of starch nanoparticles by mild alkali hydrolysis and ultra-sonication process. Sci Rep. 2020; 10(1):3533. PMC: 7044286. DOI: 10.1038/s41598-020-60380-0. View

Coates A, Hu Y . Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol. 2007; 152(8):1147-54. PMC: 2189988. DOI: 10.1038/sj.bjp.0707432. View

Jabir N, Tabrez S, Ashraf G, Shakil S, Damanhouri G, Kamal M . Nanotechnology-based approaches in anticancer research. Int J Nanomedicine. 2012; 7:4391-408. PMC: 3420598. DOI: 10.2147/IJN.S33838. View

Maksimenko A, Mougin J, Mura S, Sliwinski E, Lepeltier E, Bourgaux C . Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Cancer Lett. 2012; 334(2):346-53. DOI: 10.1016/j.canlet.2012.08.023. View

Daina A, Zoete V . A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules. ChemMedChem. 2016; 11(11):1117-21. PMC: 5089604. DOI: 10.1002/cmdc.201600182. View

Piglowska M, Kurc B, Rymaniak L, Lijewski P, Fuc P . Kinetics and Thermodynamics of Thermal Degradation of Different Starches and Estimation the OH Group and HO Content on the Surface by TG/DTG-DTA. Polymers (Basel). 2020; 12(2). PMC: 7077417. DOI: 10.3390/polym12020357. View

Montanari F, Ecker G . Prediction of drug-ABC-transporter interaction--Recent advances and future challenges. Adv Drug Deliv Rev. 2015; 86:17-26. PMC: 6422311. DOI: 10.1016/j.addr.2015.03.001. View

Crowe A, Ilett K, Karunajeewa H, Batty K, Davis T . Role of P glycoprotein in absorption of novel antimalarial drugs. Antimicrob Agents Chemother. 2006; 50(10):3504-6. PMC: 1610088. DOI: 10.1128/AAC.00708-06. View

10.

Wu W, Wang L, Wang S . Amorphous silibinin nanoparticles loaded into porous starch to enhance remarkably its solubility and bioavailability in vivo. Colloids Surf B Biointerfaces. 2020; 198:111474. DOI: 10.1016/j.colsurfb.2020.111474. View

11.

El-Mesery M, Al-Gayyar M, Salem H, Darweish M, El-Mowafy A . Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div. 2009; 4:6. PMC: 2680397. DOI: 10.1186/1747-1028-4-6. View

12.

El-Menshawe S, Ali A, Halawa A, Srag El-Din A . A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization. Drug Des Devel Ther. 2017; 11:3377-3388. PMC: 5713695. DOI: 10.2147/DDDT.S144652. View

13.

Yu C, Liu C, Wang S, Li Z, Hu H, Wan Y . Hydroxyethyl Starch-Based Nanoparticles Featured with Redox-Sensitivity and Chemo-Photothermal Therapy for Synergized Tumor Eradication. Cancers (Basel). 2019; 11(2). PMC: 6406889. DOI: 10.3390/cancers11020207. View

14.

Velasquez-Castillo L, Leite M, Ditchfield C, Sobral P, Moraes I . Quinoa starch nanocrystals production by acid hydrolysis: Kinetics and properties. Int J Biol Macromol. 2019; 143:93-101. DOI: 10.1016/j.ijbiomac.2019.12.011. View

15.

Situ W, Li X, Liu J, Chen L . Preparation and characterization of glycoprotein-resistant starch complex as a coating material for oral bioadhesive microparticles for colon-targeted polypeptide delivery. J Agric Food Chem. 2015; 63(16):4138-47. DOI: 10.1021/acs.jafc.5b00393. View

16.

Werle M . Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res. 2007; 25(3):500-11. PMC: 2265773. DOI: 10.1007/s11095-007-9347-8. View

17.

Ke Z, Hou X, Jia X . Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Des Devel Ther. 2016; 10:2049-60. PMC: 4933569. DOI: 10.2147/DDDT.S106356. View

18.

Hasanvand E, Fathi M, Bassiri A . Production and characterization of vitamin D loaded starch nanoparticles: effect of amylose to amylopectin ratio and sonication parameters. J Food Sci Technol. 2018; 55(4):1314-1324. PMC: 5876199. DOI: 10.1007/s13197-018-3042-0. View

19.

Abbasi M, Raza H, Aziz-Ur-Rehman , Siddiqui S, Shah S, Hassan M . Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses. Bioorg Chem. 2018; 83:63-75. DOI: 10.1016/j.bioorg.2018.10.018. View

20.

Elkomy M, El-Menshawe S, Ali A, Halawa A, El-Din A . Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker. Drug Deliv Transl Res. 2017; 8(1):165-177. DOI: 10.1007/s13346-017-0449-5. View